CSC research reports indicate that Ningbo Sanxing Medical (601567.SH) achieved a year-on-year net income growth of 21.91% in the first three quarters of 2024, maintaining an upward performance, with domestic and international business incremental resonance. In the first three quarters, the gross margin increased by 2.59 percentage points, reaching 36.21%, enhancing profitability. In terms of overseas business, the company has deepened its layout in overseas power business, and the breakthrough in overseas distribution continues; against the backdrop of the global smart grid, the overseas power distribution market has vast potential, and it's the right time for smart meter companies to venture abroad, opening up new increments in distribution. Regarding domestic business, the scale of domestic meter bidding in 2024 is relatively high, and the industry prosperity is strong, with the company continuously digging deep into the demands of large customers in the distribution business. Thanks to the high prosperity of power equipment, the company will fully benefit from the incremental resonance of domestic and international business. Looking ahead to the whole year, the company is expected to focus on critical recovery, relying on its rich experience in hospital chain management and internal and external talent training system, to continuously expand the layout of rehabilitation hospitals, and with the income of new hospitals rising and profit margins improving, the medical sector business is expected to achieve steady growth.